Data-Driven Decision Making

Plus Therapeutics' REYOBIQ gains a crucial CPT code, a vital step in bringing this targeted radiotherapy to patients with aggressive brain cancers.

Medtech giant reveals its 'Magnificent Seven' innovations and new data, with Chief Movement Officer Arnold Schwarzenegger leading the charge at AAOS 2026.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

With the appointment of TechTarget co-founder Don Hawk, Life Science Connect is set to import a proven B2B intent data playbook into the life sciences.

With its transformative Lanteris acquisition complete, all eyes are on Intuitive Machines' upcoming financial results for clues to its future as a space prime.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

The $20B wealth firm appoints a veteran partner as its first CEO, signaling a new era of strategic growth while doubling down on its core values.

Dupixent's landmark FDA approval offers a new, surgery-sparing option for a debilitating sinus disease, but questions of access and cost remain.

As political ad spend shifts to streaming, AdImpact launches AdMo+, a new tool designed to give campaigns a critical edge in the evolving media landscape.

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

With $14.2M in new funding, Handl Health is using AI and data to dismantle one-size-fits-all insurance, promising lower costs and better care.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

A new partnership moves past simple endorsements, offering Baylor athletes internships and career skills, setting a new standard for corporate NIL deals.

OLAPLEX launches No.3PLUS, a rapid hair repair treatment. Can this scientific leap, backed by a major celebrity campaign, reverse its financial fortunes?

With record revenue, Sigma's success highlights a major enterprise trend: businesses now demand AI that acts, not just dashboards that report on data.

A new study of 500+ leaders shows most firms use AI superficially, facing intense ROI pressure, governance hurdles, and a growing talent gap.

With a fresh $40M in funding, Letter AI is challenging sales tech incumbents by moving beyond static playbooks to real-time, deal-specific AI guidance.

New AI and data tools in Elite's 3E platform promise to slash reporting times, automate billing, and streamline global compliance for modern law firms.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.